Prescribing in pregnancy. Thyroid disease.
D013956:Antithyroid Agents / Q000009:adverse effects; D002231:Carbimazole / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007037:Hypothyroidism / Q000188:drug therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008713:Methimazole / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011433:Propranolol / Q000009:adverse effects; D011441:Propylthiouracil / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013961:Thyroid Gland / Q000196:embryology
D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil; D002231:Carbimazole; D011433:Propranolol